Joaquin Bellmunt

30PUBLICATIONS
219CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jun 02, 2026
Tumor B-cell infiltration in platinum-treated advanced muscle-invasive urothelial carcinoma.

|Jan 26, 2026
ctDNA Dynamics and Recurrence Patterns after Organ-Sparing Trimodality Therapy for Bladder Cancer.

Ilana B Epstein, Adetolani Odogiyon, Stephanie Berg

|Jan 09, 2026
Uncovering the role of ETS2 in prostate cancer pathogenesis: relationship with p53 and ERG.

Laura Segalés, Nuria Juanpere, Marta Lorenzo

|Dec 13, 2025
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.

Rana R McKay, Sumanta Pal, Wanling Xie

|Oct 01, 2025
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study.

Amanda Nizam, Charles B Nguyen, Jinju Li

|Sep 28, 2025
State-of-the-Art Imaging in Antibody-Drug Conjugate Treatment for Advanced Bladder Cancer.

Sarah Eid, Abdullah S Al-Yousef, Kyung Won Kim

Pageof 5

Frequent Collaborators

5 joint publications

Thomas Powles

5 joint publications

Petros Grivas

4 joint publications

Toni K Choueiri

3 joint publications

Lluís Cechinni